Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor
{{output}}
Inhibition of the SARS-CoV-2 main protease (Mpro) is a major focus of drug discovery efforts against COVID-19. Here we report a hit expansion of non-covalent inhibitors of Mpro. Starting from a recently discovered scaffold (The COVID Moonshot Consortium. Open ... ...
